| 000 | 01807 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515191441.0 | ||
| 264 | 0 | _c20110118 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1473-5571 | ||
| 024 | 7 |
_a10.1097/QAD.0b013e328331a456 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThuret, Isabelle | |
| 245 | 0 | 0 |
_aRaltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virus. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cNov 2009 |
||
| 300 |
_a2364-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDarunavir |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Viral |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPyridazines _xtherapeutic use |
| 650 | 0 | 4 | _aPyrimidines |
| 650 | 0 | 4 |
_aPyrrolidinones _xtherapeutic use |
| 650 | 0 | 4 | _aRaltegravir Potassium |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aChaix, Marie-Laure | |
| 700 | 1 | _aTamalet, Catherine | |
| 700 | 1 | _aReliquet, Véronique | |
| 700 | 1 | _aFirtion, Ghislaine | |
| 700 | 1 | _aTricoire, Joëlle | |
| 700 | 1 | _aRabaud, Christian | |
| 700 | 1 | _aFrange, Pierre | |
| 700 | 1 | _aAumaître, Hugues | |
| 700 | 1 | _aBlanche, Stéphane | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 23 _gno. 17 _gp. 2364-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e328331a456 _zAvailable from publisher's website |
| 999 |
_c19216675 _d19216675 |
||